Live moderated video webcast event intended to
provide the investment community direct access to ask their
questions to John Climaco, Chief
Executive Officer on Tuesday, December
6th at 11:00 AM
ET
HOUSTON, Dec. 5, 2022
/PRNewswire/ -- CNS Pharmaceuticals,
Inc. (NASDAQ: CNSP) ("CNS"
or the "Company"), a biopharmaceutical company specializing in the
development of novel treatments for primary and metastatic cancers
in the brain and central nervous system, today announced that
John Climaco, Chief Executive
Officer of CNS Pharmaceuticals, will participate in the Virtual
Investor "Ask the CEO" Event on Tuesday,
December 6, 2022 at 11:00 AM
ET.
As part of the virtual event, Mr. Climaco will provide a brief
presentation, followed by an interactive Q&A session. This "Ask
the CEO" event is intended to provide the investment community
access to ask their questions directly to Mr. Climaco. Questions
can be typed in live during the event or pre-submitted by sending
to cnsp@jtcir.com. Mr. Climaco will answer as many questions as
possible during the event.
A live video webcast of the Virtual Investor "Ask the CEO" Event
will be available on the Events page in the Investors section of
the Company's website (www.cnspharma.com). A webcast replay will be
available two hours following the live presentation and will be
accessible for 90 days.
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals a clinical-stage pharmaceutical company
developing a pipeline of anti-cancer drug candidates for the
treatment of primary and metastatic cancers of the brain and
central nervous system. The Company's lead drug candidate,
Berubicin, is a novel anthracycline and the first anthracycline to
appear to cross the blood-brain barrier. Berubicin is currently in
development for the treatment of a number of serious brain and CNS
oncology indications including glioblastoma multiforme (GBM), an
aggressive and incurable form of brain cancer.
For more information, please visit www.CNSPharma.com, and
connect with the Company on Twitter, Facebook, and LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cns-pharmaceuticals-to-participate-at-the-virtual-investor-ask-the-ceo-event-301694506.html
SOURCE CNS Pharmaceuticals, Inc.